Milestone Pharmaceuticals (MIST) Assets (2018 - 2026)

Milestone Pharmaceuticals (MIST) has reported Assets for 9 consecutive years, with $181.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Assets rose 283.04% year-over-year to $181.6 million; the trailing twelve-month figure through Jun 2026 stood at $181.6 million (up 283.04% YoY), and the FY2025 full-year result was $113.6 million, up 50.41% from the prior year.
• Assets fell to $181.6 million in Q2 2026 per MIST's latest filing, from $193.7 million in the prior quarter.
• Across five years, Assets topped out at $193.7 million in Q1 2026 and bottomed at $47.4 million in Q2 2025.
• Historically, Assets has averaged $97.6 million across 5 years, with a median of $88.5 million in 2024.
• The sharpest annual moves came in 2025 and 2026: Assets plunged 46.86% in 2025, then jumped 283.04% in 2026.
• Over 5 years, Assets stood at $74.5 million in 2022, then grew by 1.0% to $75.2 million in 2023, then climbed by 0.36% to $75.5 million in 2024, then jumped by 50.41% to $113.6 million in 2025, then surged by 59.94% to $181.6 million in 2026.
• According to Business Quant data, Assets over the past three periods registered $181.6 million, $193.7 million, and $113.6 million for Q2 2026, Q1 2026, and Q4 2025 respectively.